Merger talks, which were officially announced in October 2016, were expected to span a year. After a series of setbacks over that time, the California Justice Department conditionally approved the merger Nov. 21, marking the final major regulatory nod. Other hospital news focuses on: strategies to lure cash-paying patients, pricing transparency, federal funding and more.
from Kaiser Health News http://bit.ly/2S86YGZ
February 04, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Journalists Review 2022’s Top Health Stories and the CDC’s Policy on Remote WorkKHN Florida correspondent Daniel Chang discussed some of 2022’s top health stories from the Sunshine State on WLRN Miami’s “The Florida Roundup” on Dec. 29. Click here to hear Chang on “The Florida Roundup“ KHN senior edito… Read More
Listen: Who Investigates Suspicious Deaths in Your Community — And Why It MattersEach state has its own laws governing the investigation of violent and unexplained deaths, and the expertise and training of those in charge of such investigations vary widely across the nation. The job can be held by an elec… Read More
Medicaid and Abortion Top Health Agenda for Montana LawmakersHELENA, Mont. — Montana lawmakers said lowering costs and expanding patient access will be their top health care goals for the new legislative session. But they also will have to contend with making changes to Medicaid, a man… Read More
Behavioral Telehealth Loses Momentum Without a Regulatory BoostControlled substances became a little less controlled during the pandemic. That benefited both patients (for their health) and telehealth startups (to make money). Some potentially addictive medications — like buprenorphine a… Read More
The Decision of Where to Seek Care Is Complicated by the Multitude of OptionsOne evening in February 2017, Sarah Dudley’s husband, Joseph, started to feel sick. He had a high fever, his head and body ached, and he seemed disoriented, she said. The Dudleys had a decision to make: go to the hospital eme… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment